Holen Sie sich die Stockscreener-App
97.97
0.27%
0.26
Schlusskurs vom Vortag:
$97.71
Offen:
$97.55
24-Stunden-Volumen:
290.48K
Relative Volume:
0.74
Marktkapitalisierung:
$3.22B
Einnahmen:
$2.32B
Nettoeinkommen (Verlust:
$82.93M
KGV:
38.88
EPS:
2.52
Netto-Cashflow:
$203.54M
1W Leistung:
+0.47%
1M Leistung:
+0.52%
6M Leistung:
+6.40%
1J Leistung:
+0.53%
1-Tages-Spanne:
$97.55
$98.01
1-Wochen-Bereich:
$96.99
$98.01
52-Wochen-Spanne:
$82.15
$98.95
Amedisys Inc Stock (AMED) Company Profile
Firmenname
Amedisys Inc
Sektor
Branche
Telefon
(225) 292-2031
Adresse
3854 AMERICAN WAY, BATON ROUGE, LA
Vergleichen Sie AMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
97.97 | 3.20B | 2.32B | 82.93M | 203.54M | 2.52 |
|
HCA
Hca Healthcare Inc
|
350.97 | 89.45B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.80 | 15.77B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
155.97 | 16.05B | 20.52B | 1.46B | 1.41B | 15.12 |
|
DVA
Davita Inc
|
146.05 | 10.62B | 12.82B | 936.34M | 1.47B | 10.74 |
|
EHC
Encompass Health Corp
|
108.39 | 10.81B | 5.51B | 494.70M | 386.40M | 4.84 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-07 | Herabstufung | Truist | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-03-13 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-27 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-08-02 | Herabstufung | UBS | Neutral → Sell |
| 2022-06-29 | Eingeleitet | Stifel | Hold |
| 2022-06-21 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-01 | Hochstufung | UBS | Sell → Neutral |
| 2022-02-25 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-02-25 | Bestätigt | Credit Suisse | Outperform |
| 2022-02-25 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-25 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-02-25 | Bestätigt | Raymond James | Outperform |
| 2022-02-25 | Bestätigt | Truist | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-10 | Bestätigt | The Benchmark Company | Buy |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-08-20 | Fortgesetzt | Barclays | Overweight |
| 2020-07-30 | Bestätigt | The Benchmark Company | Buy |
| 2020-06-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-05-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-03-09 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-01-17 | Eingeleitet | Credit Suisse | Outperform |
| 2019-11-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-22 | Fortgesetzt | Stephens | Equal-Weight |
| 2019-09-17 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-12-14 | Eingeleitet | Barclays | Equal Weight |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-10-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2018-07-03 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-03-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-11-09 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-11-08 | Bestätigt | Mizuho | Buy |
| 2017-11-02 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-08-21 | Eingeleitet | BofA/Merrill | Neutral |
Alle ansehen
Amedisys Inc Aktie (AMED) Neueste Nachrichten
Amedisys Inc. Stock Analysis and ForecastTriple returns potential - Autocar Professional
What analysts say about Amedisys Inc. stockSkyrocketing returns - jammulinksnews.com
What drives Amedisys Inc. stock priceExceptional stock performance - jammulinksnews.com
Is Amedisys Inc. a good long term investmentBreakthrough profit margins - jammulinksnews.com
What Does Amedisys, Inc.'s (NASDAQ:AMED) Share Price Indicate? - Yahoo Finance
Amedisys AMED Q2 2025 Earnings Preview Upside Anticipated on Robust Revenue Growth - AInvest
Amedisys, Inc.'s (NASDAQ:AMED) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock? - simplywall.st
Investor Optimism Abounds Amedisys, Inc. (NASDAQ:AMED) But Growth Is Lacking - 富途牛牛
How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts - Barron's
AMED SEC FilingsAmedisys Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Amedisys Inc (AMED) Stock Analysis: Evaluating Market Position Amidst Modest Revenue Growth - DirectorsTalk Interviews
Home Care Service Market Is Booming Worldwide | Amedisys Inc., LHC Group Inc., Brookdale Senior Living Inc. - openPR.com
Here's Why You Should Retain AMED Stock in Your Portfolio for Now - The Globe and Mail
There's Reason For Concern Over Amedisys, Inc.'s (NASDAQ:AMED) Price - simplywall.st
Chief Accounting Officer Guidroz Allyson covered exercise/tax liability with 171 shares, decreasing direct ownership by 2% to 7,943 units (SEC Form 4) - Quantisnow
Home Care Service Market Future Business Opportunities - openPR.com
Amedisys Inc (AMED) Stock Analysis: Evaluating the 3.67% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Is UnitedHealth the Boeing of Healthcare? Why It May Be Too Big to Break - Investing.com
Amedisys (AMED) Down 0.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Are Medical Stocks Lagging Amedisys (AMED) This Year? - Yahoo Finance
DOJ Reportedly Investigates UnitedHealth’s Medicare Advantage Business, UHG Pushes Back - Home Health Care News
2,372 Shares in Amedisys, Inc. (NASDAQ:AMED) Acquired by Raymond James Financial Inc. - Defense World
UnitedHealth Group CEO Andrew Witty Steps Down, Company Suspends 2025 Financial Forecast - Home Health Care News
DOJ Rejects Amedisys, UnitedHealth’s Divestiture to BrightSpring, Pennant - Hospice News
Amedisys (AMED) Faces DOJ Hurdle in UnitedHealth Deal - GuruFocus
Amedisys edges lower on report DOJ initially rejects remedy in UnitedHealth - Seeking Alpha
Amedisys, Inc. (NASDAQ:AMED) Shares Purchased by Schonfeld Strategic Advisors LLC - The AM Reporter
Amedisys Executive Makes Notable Stock Sale - TipRanks
US magistrate judge schedules UnitedHealth, Optum-Amedisys mediation conference - MLex
What Mediation Means For The UnitedHealth Group, Amedisys Deal - Home Health Care News
Pennant Sees Record-Breaking Quarter on Hospice, Home Health Growth - Hospice News
Director Kline Teresa L. was granted 1,690 shares, increasing direct ownership by 21% to 9,818 units (SEC Form 4) - Quantisnow
Director Capps Vickie L was granted 1,690 shares, increasing direct ownership by 21% to 9,818 units (SEC Form 4) - Quantisnow
Director Samuels Ivanetta Davis was granted 1,690 shares, increasing direct ownership by 29% to 7,600 units (SEC Form 4) - Quantisnow
UnitedHealth, Amedisys reach new deal to sell home health and hospice locations if merger approved - Healthcare Dive
Amedisys Deal Would Bring BrightSpring Into Range of New Markets - Hospice News
UnitedHealth, Amedisys strike deals to sell home care locations - Modern Healthcare
Amedisys, Inc. to Host Earnings Call - ACCESS Newswire
Amedisys to Divest Hospice, Home Health Locations to BrightSpring, The Pennant Group - Hospice News
Wells Fargo & Company MN Grows Stock Holdings in Amedisys, Inc. (NASDAQ:AMED) - Defense World
Finanzdaten der Amedisys Inc-Aktie (AMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):